Gómez, Ana Villar
Rodríguez-Nieto, M.J.
Cano-Jiménez, E.
Ortiz, A. Romero
Morros, M.
Ramon, A.
Armengol, S.
Funding for this research was provided by:
Boehringer Ingelheim España
Article History
Received: 26 October 2023
Accepted: 25 July 2024
First Online: 31 July 2024
Declarations
:
: The study was approved by the Ethical Board (EB) of all participant hospitals. The EB of H. Fundación Jiménez Díaz in Madrid, Spain, acted as reference ethics committee. Detailed information about OASIS study can be found elsewhere []. Written informed consent prior to participation was collected from all participants.
: Consent for Publication Not Applicable.
: AV has received consulting fees from Boehringer Ingelheim and Roche; fees for talks/lectures from Boehringer Ingelheim, GlaxoSmithKline and Roche; and funding for conferences attendances and courses from Boehringer Ingelheim, Chiesi, Novartis and Roche. MJRN has received funding for research (data monitoring boards), consulting fees and honoraria for presentations/lectures and for being an advisor from Boehringer Ingelheim and Roche. ECJ has received funding for research and consulting fees for presentations/lectures and for being an advisor from Boehringer Ingelheim, Galapagos and Roche. ADRO has received funding for research and consulting fees for presentations/lectures and for being an advisor from Boehringer Ingelheim and Roche. MM is a full-time employee of Adelphi Targis. AR and SA are full-time employees of Boehringer Ingelheim España.